blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2205564

EP2205564 - NOVEL KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.06.2015
Database last updated on 14.03.2026
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): MT		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstraße 124
4070 Basel / CH
[2014/31]
Former [2010/28]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / DEWDNEY, Nolan James
14595 Horseshoe Drive
Saratoga California 95070 / US
02 / GABRIEL, Tobias
Aeschenvorstadt 15
CH-4051 Basel / CH
03 / KONDRU, Rama K.
33 Gatheringhill Court
Morris Plains New Jersey 07950 / US
04 / LOU, Yan
1740 Fallbrook Avenue
San Jose California 95103 / US
05 / SOTH, Michael
10 Hillview Terrace
Glen Rock New Jersey 07452 / US
 [2010/42]
Former [2010/36]01 / DEWDNEY, Nolan James
14595 Horseshoe Drive
Saratoga California 95070 / US
02 / GABRIEL, Tobias
Aeschenvorstadt 15
CH-4051 Basel / CH
03 / KONDRU, Rama K.
33 Gatheringhill Court
Morris Plains New Jersey 07950 / US
04 / LOU, Yan
1740 Fallbrook Avenue
San Jose California 95103 / US
05 / SOTH, Michael
2321 Edsel Drive
Milpitas California 95035 / US
Former [2010/28]01 / DEWDNEY, Nolan James
14595 Horseshoe Drive
Saratoga California 95070 / US
02 / GABRIEL, Tobias
Aeschenvorstadt 15
CH-4051 Basel / CH
03 / KONDRU, Rama K.
1026 Aster Avenue, 2118
Sunnyvale California 94086 / US
04 / LOU, Yan
1740 Fallbrook Avenue
San Jose California 95103 / US
05 / SOTH, Michael
2321 Edsel Drive
Milpitas California 95035 / US
Representative(s)Sauer, Frank
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2014/31]Sauer, Frank
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
Former [2010/28]Sauer, Frank
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
Application number, filing date08805263.414.10.2008
[2010/28]
WO2008EP63758
Priority number, dateUS2007000013923.10.2007         Original published format: US 139
US2008008641605.08.2008         Original published format: US 86416
[2010/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009053269
Date:30.04.2009
Language:EN
[2009/18]
Type: A1 Application with search report 
No.:EP2205564
Date:14.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 30.04.2009 takes the place of the publication of the European patent application.
[2010/28]
Type: B1 Patent specification 
No.:EP2205564
Date:30.07.2014
Language:EN
[2014/31]
Search report(s)International search report - published on:EP30.04.2009
ClassificationIPC:C07D213/63, C07D401/12, C07D401/14, C07D403/14, C07D409/12, C07D413/12, C07D413/14, A61K31/4412, A61K31/501, A61P9/02
[2010/28]
CPC:
C07D213/63 (EP,US); A61P1/04 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P37/00 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P7/04 (EP); A61P7/06 (EP);
A61P9/02 (EP); A61P9/10 (EP); A61P9/14 (EP);
C07D401/12 (EP,US); C07D401/14 (EP,US); C07D403/14 (EP,US);
C07D409/12 (EP,US); C07D413/12 (EP,US); C07D413/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/28]
TitleGerman:NEUE KINASEINHIBITOREN[2010/28]
English:NOVEL KINASE INHIBITORS[2010/28]
French:NOUVEAUX INHIBITEURS DE KINASE[2010/28]
Entry into regional phase25.05.2010National basic fee paid 
25.05.2010Designation fee(s) paid 
25.05.2010Examination fee paid 
Examination procedure25.05.2010Examination requested  [2010/28]
02.07.2010Amendment by applicant (claims and/or description)
21.04.2011Despatch of a communication from the examining division (Time limit: M06)
14.09.2011Reply to a communication from the examining division
18.02.2014Communication of intention to grant the patent
05.06.2014Fee for grant paid
05.06.2014Fee for publishing/printing paid
05.06.2014Receipt of the translation of the claim(s)
Divisional application(s)EP11184324.9  / EP2426109
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.04.2011
Opposition(s)04.05.2015No opposition filed within time limit [2015/28]
Fees paidRenewal fee
23.09.2010Renewal fee patent year 03
10.10.2011Renewal fee patent year 04
05.10.2012Renewal fee patent year 05
07.10.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.10.2008
AT30.07.2014
BE30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
MC30.07.2014
MT30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SI30.07.2014
SK30.07.2014
IE14.10.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
[2016/33]
Former [2016/32]HU14.10.2008
AT30.07.2014
BE30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
MC30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SI30.07.2014
SK30.07.2014
IE14.10.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/50]AT30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
MC30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SI30.07.2014
SK30.07.2014
IE14.10.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
BE31.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/46]AT30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
MC30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SK30.07.2014
IE14.10.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
BE31.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/30]AT30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
MC30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SK30.07.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
BE31.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/27]AT30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
MC30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SK30.07.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/26]AT30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SK30.07.2014
LU14.10.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/23]AT30.07.2014
CY30.07.2014
CZ30.07.2014
DK30.07.2014
EE30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
SK30.07.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/22]AT30.07.2014
CY30.07.2014
DK30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
NL30.07.2014
PL30.07.2014
RO30.07.2014
SE30.07.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/12]AT30.07.2014
CY30.07.2014
FI30.07.2014
HR30.07.2014
LT30.07.2014
LV30.07.2014
NL30.07.2014
PL30.07.2014
SE30.07.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
IS30.11.2014
PT02.12.2014
Former [2015/11]CY30.07.2014
FI30.07.2014
LT30.07.2014
PL30.07.2014
SE30.07.2014
BG30.10.2014
NO30.10.2014
GR31.10.2014
PT02.12.2014
Former [2015/10]FI30.07.2014
LT30.07.2014
SE30.07.2014
BG30.10.2014
NO30.10.2014
Former [2015/09]FI30.07.2014
LT30.07.2014
SE30.07.2014
Former [2015/08]LT30.07.2014
Cited inby applicant  KHAN ET AL., IMMUNITY, vol. 3, 1995, pages 283
   ELLMEIER ET AL., J. EXP. MED., vol. 192, 2000, pages 1611
   ROSEN ET AL., NEW ENG. J. MED., vol. 333, 1995, pages 431
   LINDVALL ET AL., LMMUNOL. REV., vol. 203, 2005, pages 200
   JANSSON; HOLMDAHL, CLIN. EXP, IMMUNOL., vol. 94, 1993, pages 459
   PAN ET AL., CHEM. MED CHEM., vol. 2, 2007, pages 58 - 61
   IWAKI ET AL., J. BIOL. CHEM., vol. 280, 2005, pages 40261
   HORWOOD ET AL., J EXP MED, vol. 197, 2003, pages 1603
   ISLAM; SMITH, IMMUNOL. REV., vol. 178, 2000, pages 49
   FELDHAHN ET AL., J. EXP. MED., vol. 201, 2005, pages 1837
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.